COVID-19
Not recruitingStudy of GS-5245 for Treating COVID-19 in Children and Adolescents
Study of GS-5245 for Treating COVID-19 in Children and Adolescents
Bulgaria- Participants:0–17 years
- Substances:Gs-5245
Rare diseases
Investigational molecules
Locations
Study of GS-5245 for Treating COVID-19 in Children and Adolescents
BulgariaStudy Comparing Pembrolizumab and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer
BelgiumStudy Comparing Enfortumab Vedotin and Pembrolizumab with Chemotherapy for Patients with Muscle-Invasive Bladder Cancer
BulgariaStudy of Pembrolizumab, Trastuzumab, and Chemotherapy for Patients with HER2 Positive Advanced Stomach or Gastroesophageal Junction Cancer
FranceStudy of NMS-03592088 for Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)
FranceStudy on the Effectiveness and Safety of Ocrelizumab, Methylprednisolone, and Diphenhydramine Hydrochloride in Patients with Multiple Sclerosis
BelgiumStudy of Adagrasib Dosing in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation
CroatiaStudy Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer
AustriaStudy on Brentuximab Vedotin and Drug Combination for Patients with Peripheral T-cell Lymphoma with Less Than 10% CD30 Expression
FranceStudy on the Effectiveness and Safety of SAR441566 for Adults with Moderate to Severe Plaque Psoriasis
BulgariaStudy on Holmium-166 TARE and Maintenance Therapy with Capecitabine, Bevacizumab, and Drug Combination for Patients with Unresectable Liver-Colorectal Cancer
ItalyStudy on the Safety and Effects of BAY 2599023 (Peboctocogene Camaparvovec) for Adults with Severe Hemophilia A
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.